The Electronic Pharmaceutical Record: A new method for medication reconciliation

Journal of Evaluation in Clinical Practice
Camille JuradoBrigitte Sallerin

Abstract

There are several ways to establish an accurate medication list in the hospital admission medication reconciliation (MedRec). The challenge for MedRec lies in the availability, reliability, and completeness of the data used. In France, the Electronic Pharmaceutical Record (ePR) was developed to register each medication taken by ambulatory patients, primarily to make dispensation in community pharmacies safe. We evaluated the suitability of this tool in the MedRec when patients were admitted to the hospital. We conducted a 6-month pilot study of 249 MedRec files from a hospital diabetology department. The analysis was supplemented by the ePR for any patient for whom this information was recorded. The study evaluated the ePR as a new MedRec tool, as well as the clinical impact (CI) of the new data collected. The ePR was contributory for 28% of the patients. Discrepancies were associated with polypharmacy, most of which had a CI = 1. Medication omission was the most frequently found discrepancy (72%), but self-medication (8%) and lack of medication adherence (9%) were also observed. This tool provided added value for reconciliation, as it quickly identifies regular medications, adherence, and self-medication behaviour. The ePR is ...Continue Reading

References

Jan 1, 1997·Journal of Clinical Epidemiology·J F Steiner, A V Prochazka
Jul 23, 1998·Clinical Pharmacokinetics·A HämmerleinD T Lowenthal
Jan 16, 2002·JAMA : the Journal of the American Medical Association·David W KaufmanAllen A Mitchell
Dec 31, 2004·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Charles Marc SamamaUNKNOWN Agence Française de Sécurité Sanitaire des Produits de Santé expert group
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Sep 1, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Vincent C TamEdward E Etchells
Sep 27, 2006·Archives of Internal Medicine·P Michael HoDavid J Magid
Sep 4, 2007·British Journal of Clinical Pharmacology·Bente GlintborgKim P Dalhoff
Jun 11, 2010·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·James M NaessensJeanne M Huddleston
Jul 10, 2010·Current Drug Safety·Maria Esperanza Ruiz
Oct 7, 2010·The Annals of Pharmacotherapy·Mónica Climente-MartíN Víctor Jiménez-Torres
Jul 30, 2011·Journal of the American Geriatrics Society·Michael A SteinmanKenneth E Covinsky
Nov 19, 2011·Journal of the American Geriatrics Society·A Clara Drenth-van MaanenRob J van Marum
Jan 3, 2012·Diabetes & Metabolism·B VergèsUNKNOWN Diabetes and Cardiovascular Disease study group of the Société francophone du diabète (SFD), in collaboration with the Socié
Oct 27, 2012·Diabetes Care·M Sue KirkmanCarrie S Swift
Mar 6, 2013·Annals of Internal Medicine·Janice L KwanKaveh G Shojania
Mar 22, 2013·European Journal of Internal Medicine·Baptiste QuélennecBruno Michel
Jul 9, 2013·Diabetes Research and Clinical Practice·I Bourdel-MarchassonA Fagot-Campagna
Nov 23, 2013·BMC Health Services Research·Ari N MeguerditchianRobyn Tamblyn
Oct 11, 2014·Journal of Clinical Pharmacy and Therapeutics·P BedouchUNKNOWN French Society of Clinical Pharmacy's Act-IP© Group
Apr 8, 2016·International Journal of Clinical Pharmacy·Marlies M E GeurtsJohan J de Gier
Jun 13, 2016·European Journal of Internal Medicine·Carole E AubertNicolas Rodondi
Jul 27, 2017·European Journal of Clinical Pharmacology·Julie HiasSabrina De Winter

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

PloS One
Gabriella Fernandes MagalhãesLúcia de Araújo Costa Beisl Noblat
The American Journal of Medicine
Stephen D PersellMichael S Wolf
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
L RenteroM D Pérez
© 2022 Meta ULC. All rights reserved